Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer's Disease: A Re-Analysis of the CATIE-AD Study.

CONCLUSIONS: Although further research to validate these preliminary findings is needed, focusing on early improvements of individual symptoms could help identify subsequent treatment responders to antipsychotics in AD patients with NPSs. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00015548. PMID: 32074412 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32074412?dopt=Abstract

Source: Journal of Clinical Psychiatry - February 21, 2020 Category: Psychiatry Tags: J Clin Psychiatry Source Type: research